Pivotal results from the Phase 3 Breakwater trial showed 51% risk reduction in death compared to standard-of-care treatment
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Shelter Pharma Limited is set to capitalize on the growing demand for natural health products in India
Scores highest PAT of Rs. 118 crore in FY25
The Q1 2025 also witnessed a successful launch of Allegra D
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Subscribe To Our Newsletter & Stay Updated
